psylo_news Josh Ismin 17/6/22 psylo_news Josh Ismin 17/6/22 Psylo on Hamilton Morris’ Podcast Read More psylo_news Josh Ismin 17/6/22 psylo_news Josh Ismin 17/6/22 Psylo and NIDA announce Collaborative Research Agreement Read More psych_news Guest User 6/6/22 psych_news Guest User 6/6/22 How psychedelic drugs might treat depression Read More psylo_news Josh Ismin 5/6/22 psylo_news Josh Ismin 5/6/22 The Future of Drugs at Vivid Ideas Festival Read More psych_news Guest User 3/6/22 psych_news Guest User 3/6/22 New study to evaluate psilocybin's therapeutic potential on autistic adults Read More psych_news Guest User 31/5/22 psych_news Guest User 31/5/22 Can you take the trip out of psychedelics and still treat depression? Read More psylo_news Josh Ismin 28/5/22 psylo_news Josh Ismin 28/5/22 Dr Sam Banister at Pint of Science Read More psylo_news Josh Ismin 28/5/22 psylo_news Josh Ismin 28/5/22 Dr Dilara Bahceci at Pint of Science Read More psylo_news Josh Ismin 28/5/22 psylo_news Josh Ismin 28/5/22 Psylo awarded Kickstart grant from CSIRO Read More psylo_newsletters Guest User 26/5/22 psylo_newsletters Guest User 26/5/22 Psylo Newsletter - May 2022 Read More psych_news Guest User 24/5/22 psych_news Guest User 24/5/22 $2.7M grant from NIDA to find to develop non-hallucinogenic psychedelic analogues for substance use disorders Read More psylo_news Josh Ismin 23/5/22 psylo_news Josh Ismin 23/5/22 Psylo on Soma Collective Podcast Read More psylo_news Josh Ismin 20/5/22 psylo_news Josh Ismin 20/5/22 Psylo in Cosmos Magazine Read More psych_news Guest User 17/5/22 psych_news Guest User 17/5/22 CSIRO starts work on medicinal psychedelics Read More psych_news Guest User 16/5/22 psych_news Guest User 16/5/22 Inside the Dispute Over a High-Profile Psychedelic Study Read More psych_news Guest User 11/5/22 psych_news Guest User 11/5/22 MindMed Collaborators Prof. Liechti and Dr. Holze Announce Positive Topline Data from Phase 2 Trial Evaluating LSD in Anxiety Disorders Read More psych_news Guest User 9/5/22 psych_news Guest User 9/5/22 Europe’s first psychedelic drug trial firm to open in London Read More psych_news Guest User 9/5/22 psych_news Guest User 9/5/22 MAPS Completes Enrollment, as Planned, for the Confirmatory Phase 3 Trial of MDMA-Assisted Therapy for PTSD Read More psylo_news Josh Ismin 3/5/22 psylo_news Josh Ismin 3/5/22 Psylo in the metaverse Read More psylo_newsletters Guest User 28/4/22 psylo_newsletters Guest User 28/4/22 Psylo Newsletter - April 2022 Read More Newer Posts Older Posts
psylo_news Josh Ismin 17/6/22 psylo_news Josh Ismin 17/6/22 Psylo on Hamilton Morris’ Podcast Read More
psylo_news Josh Ismin 17/6/22 psylo_news Josh Ismin 17/6/22 Psylo and NIDA announce Collaborative Research Agreement Read More
psych_news Guest User 6/6/22 psych_news Guest User 6/6/22 How psychedelic drugs might treat depression Read More
psylo_news Josh Ismin 5/6/22 psylo_news Josh Ismin 5/6/22 The Future of Drugs at Vivid Ideas Festival Read More
psych_news Guest User 3/6/22 psych_news Guest User 3/6/22 New study to evaluate psilocybin's therapeutic potential on autistic adults Read More
psych_news Guest User 31/5/22 psych_news Guest User 31/5/22 Can you take the trip out of psychedelics and still treat depression? Read More
psylo_news Josh Ismin 28/5/22 psylo_news Josh Ismin 28/5/22 Dr Sam Banister at Pint of Science Read More
psylo_news Josh Ismin 28/5/22 psylo_news Josh Ismin 28/5/22 Dr Dilara Bahceci at Pint of Science Read More
psylo_news Josh Ismin 28/5/22 psylo_news Josh Ismin 28/5/22 Psylo awarded Kickstart grant from CSIRO Read More
psylo_newsletters Guest User 26/5/22 psylo_newsletters Guest User 26/5/22 Psylo Newsletter - May 2022 Read More
psych_news Guest User 24/5/22 psych_news Guest User 24/5/22 $2.7M grant from NIDA to find to develop non-hallucinogenic psychedelic analogues for substance use disorders Read More
psylo_news Josh Ismin 23/5/22 psylo_news Josh Ismin 23/5/22 Psylo on Soma Collective Podcast Read More
psych_news Guest User 17/5/22 psych_news Guest User 17/5/22 CSIRO starts work on medicinal psychedelics Read More
psych_news Guest User 16/5/22 psych_news Guest User 16/5/22 Inside the Dispute Over a High-Profile Psychedelic Study Read More
psych_news Guest User 11/5/22 psych_news Guest User 11/5/22 MindMed Collaborators Prof. Liechti and Dr. Holze Announce Positive Topline Data from Phase 2 Trial Evaluating LSD in Anxiety Disorders Read More
psych_news Guest User 9/5/22 psych_news Guest User 9/5/22 Europe’s first psychedelic drug trial firm to open in London Read More
psych_news Guest User 9/5/22 psych_news Guest User 9/5/22 MAPS Completes Enrollment, as Planned, for the Confirmatory Phase 3 Trial of MDMA-Assisted Therapy for PTSD Read More
psylo_newsletters Guest User 28/4/22 psylo_newsletters Guest User 28/4/22 Psylo Newsletter - April 2022 Read More
